The primary management tactic for lepidopteran pests of cotton in the United
States of America (USA) is the use of transgenic cotton that produces
Bacillus thuringiensis Berliner (Bt)
toxins. The primary target pests of this technology are Helicoverpa
zea (Boddie) and Heliothis virescens (F.) in the
eastern and central Cotton Belt of the USA. Concerns over the evolution of
resistance in H. zea to Bt
toxins and scrutiny of the necessity of Bt crops has escalated.
We reviewed published and unpublished data from field trials of
Bt cotton in the eastern and central Cotton Belt of the USA
through 2015 to evaluate the effectiveness of Bt cotton
(Bollgard, Bollgard II, WideStrike, WideStrike 3, and TwinLink).
Bt cotton reduced insecticide usage, reduced heliothine
pest numbers and damage, and provided a yield benefit, but Bollgard II and
WideStrike efficacy declined in the Midsouth over the period evaluated. In the
Southeastern region, heliothine damage remained constant through 2015, but yield
benefits declined from 2010 until 2015. Resistance of H.
zea to several Bt toxins is the most
plausible explanation for the observed changes in Bt cotton
efficacy. The introduction of new Bt toxins such as found in
Widestrike 3 and Twinlink may preserve the benefits of Bt
crops. However, while both Widestrike 3 and Twinlink had less damage than
Widestrike, damage levels of both were similar to Bollgard II.
BioOne Complete (complete.BioOne.org) is a full-text database of 200 subscribed and open-access titles in the biological, ecological, and environmental sciences published by nonprofit societies, associations, museums, institutions, and presses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.